ZENO - Zenosense, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
-
-
0
32
Selling General and Administrative
149
159
134
114
Total Operating Expenses
149
159
134
146
Operating Income or Loss
-149
-159
-134
-146
Interest Expense
237
252
72
4
Total Other Income/Expenses Net
-99
-155
-43
0
Income Before Tax
-485
-566
-249
-150
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-485
-566
-249
-150
Net Income
-485
-566
-249
-150
Net Income available to common shareholders
-485
-566
-249
-150
Reported EPS
Basic
-
-0.03
-0.02
-0.02
Diluted
-
-0.03
-0.02
-0.02
Weighted average shares outstanding
Basic
-
21,142
12,564
7,088
Diluted
-
21,142
12,564
7,088
EBITDA
-
-314
-178
-146